CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Stemline Therapeutics Inc  (STML)
Other Ticker:  
 

Cumulative Stemline Therapeutics Inc's Quick Ratio for Trailing Twelve Months Period

STML's Quick Ratio for Trailing Twelve Months Period and Cash & cash equivalent, Current Liabilities growth



STML Quick Ratio for Trailing Twelve Months Period

(Dec 31 2018)
IV. Quarter
(Sep 30 2018)
III. Quarter
(Jun 30 2018)
II. Quarter
(Mar 31 2018)
I. Quarter
(Dec 31 2017)
IV. Quarter
Y / Y Current Liabilities Growth 6.96 % 19.84 % 31.61 % 48.32 % 93.48 %
Y / Y Cash & cash equivalent Growth 16.21 % 19.85 % 50.02 % 10.99 % 10.33 %
Quick Ratio for Trailing Twelve Months Period 4.37 4.34 4.34 4.14 4.41
Total Ranking # 637 # 565 # 530 # 562 # 536
Seq. Current Liabilities Growth 22.4 % -5.2 % -6.64 % -1.28 % 37.15 %
Seq. Cash & cash equivalent Growth -23.47 % -18.31 % -3.38 % 92.4 % -21.07 %


Quick Ratio for Trailing Twelve Months Period Comment
On the trailing twelve months basis Stemline Therapeutics Inc Cash & cash equivalent average increased by 16.21 % in IV. Quarter year on year, faster than Current Liabilities, this led to increase in in Stemline Therapeutics Inc's Quick Ratio for Trailing Twelve Months Period to 4.37, Quick Ratio for Trailing Twelve Months Period remained below Stemline Therapeutics Inc average.
Quick Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Major Pharmaceutical Preparations industry 154 other companies have achieved higher Quick Ratio for Trailing Twelve Months Period than Stemline Therapeutics Inc. While Quick Ratio for Trailing Twelve Months Period total ranking has deteriorated compare to previous quarter from 565 to 637.

What is Quick Ratio?
Learn more about STML
Quick Ratio STML in the most recent quarter
Quick Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 155
Sector # 312
S&P 500 # 630


Quick Ratio for Trailing Twelve Months Period Statistics
High Average Low
17.45 7.87 3.72
(Dec. 30, 2013)   (Dec 31 2018)




Companies with similar average Quick Ratio for Trailing Twelve Months Period for 12 months ending Dec 31 2018, within Major Pharmaceutical Preparations Industry Quick Ratio for Trailing Twelve Months Period
Marinus Pharmaceuticals Inc  12.02 
Blueprint Medicines Corp  11.70 
Arbutus Biopharma Corp  11.56 
Siga Technologies Inc  11.36 
Spring Bank Pharmaceuticals, Inc.  11.31 
Zafgen, Inc.  11.14 
Concert Pharmaceuticals, Inc.  11.06 
Chimerix Inc  10.61 
Proqr Therapeutics N.v.  10.49 
Revance Therapeutics, Inc.  10.43 
Biohaven Pharmaceutical Holding Co Ltd.  10.39 
Flexion Therapeutics Inc  10.37 
Zogenix, Inc.  10.26 
Nektar Therapeutics  10.24 
Aquinox Pharmaceuticals, Inc  10.21 
Marker Therapeutics, Inc.  10.15 
Forty Seven, Inc.  10.13 
Alnylam Pharmaceuticals, Inc.  10.05 
Steadymed Ltd.  9.94 
Mirati Therapeutics, Inc.  9.89 
Insmed Inc  9.84 
Mei Pharma, Inc.  9.77 
Ardelyx, Inc.  9.73 
Constellation Pharmaceuticals Inc  9.65 
Kala Pharmaceuticals, Inc.  9.55 
Millendo Therapeutics, Inc.  9.40 
Cytokinetics Inc  9.40 
Epizyme, Inc.  9.40 
Oragenics Inc  9.36 
Beigene, Ltd.  9.35 


             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

HICKA's Profile

Stock Price

HICKA's Financials

Business Description

Fundamentals

Charts & Quotes

HICKA's News

Suppliers

HICKA's Competitors

Customers & Markets

Economic Indicators

HICKA's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071